Experience a different kind of PBM We’re your trusted, transparent partner that’s reimagining pharmacy solutions to deliver value back to those we serve and transforming our industry for the...

Upgrade provides streamlined patient support and enhanced digital engagement for data-driven, holistic care

Event will feature David Lassen, chief clinical officer

Prime Careers Spotlight: November 2024 Check out our latest job openings. Together, we can help make health care better by helping clients and members navigate pharmacy benefits. Investment...

Annual conference features presentations, panels, discussions and networking

Notice of Privacy Practices To allow a family member or agent to contact Prime on your behalf, please print, complete and return the release form below: Authorization for Release of Information |...

Breadcrumb Home Newsroom Custom Content Publications High-Cost Therapy Profile: September 2024 PUBLIcATIonS High-Cost Therapy Profile: September 2024 Detailed information about Intravenous (IV)...

PUBLICATIONS FDA Decisions Expected: April 2025 Your monthly synopsis of new drugs expected to hit the market March 14, 2025 Drug pipeline for April 2025 At Prime Therapeutics (Prime), we have...

Cover image for Prime Therapeutics prioritizes patient-centered care, stays ahead of oncology trends Prime simplifies the cancer care pathway through innovative solutions that help manage complex...

Breadcrumb Home Newsroom Custom Content Prime Careers Spotlight Prime Careers Spotlight: July 2025 Prime Careers Spotlight: July 2025 Check out our latest job openings. Together, we can help make...

Dinesh Kandanchatha joined the organization July 1.

publications Drug Approvals: November 2024 Critical updates in an ever-changing environment This monthly update of United States (U.S.) Food and Drug Administration (FDA) approvals provides a...

Managed Markets Insight & Technology (MMIT)

publications BiTEs and roadblocks June 25, 2025 Author: Simone Ndujiuba, PharmD, BCOP US Food and Drug Administration (FDA) has approved fourteen bispecific antibody drugs to treat a variety of...

Expert Clinical Network Insights Metastatic Synovial Sarcoma October 21, 2024 Medication insights: afamitresgene autoleucel (Tecelra) The U.S. Food and Drug Administration (FDA) approved...

Start a medication therapy management internship Get hands-on pharmacy experience and develop leadership, strategic-planning and patient care skills with our medication therapy management and...

Second annual report gives a transparent overview of Prime’s organizational makeup, highlights milestones along its journey

oncology insights Decoding Cancer: How Genetic and Genomic Testing Advance Treatment December 13, 2024 Scientists have made remarkable progress in understanding the thousands of genes inside our...

Latest edition of Prime Therapeutics Report spotlights seismic shift in how best to diagnose and manage transthyretin amyloid cardiomyopathy (ATTR-CM) and what it means for patients, providers and...

Perspectives Oncology Insights: First-in-class bladder cancer therapy and the Bacillus Calmette-Guérin (BCG) shortage Approximately 83,000 new bladder cancer cases are diagnosed in the U.S. in each...